Could Targeting Brain Inflammation Be The Answer To Alzheimer's Disease?
Recently, NBC News released a report by Dr. Rudi Tanzi, from Massachusetts General Hospital. He has discovered inflammation kills millions of nerve cells, shutting down the area responsible for thinking and memory. Could this be link be a between nervous system inflammation and memory play a factor in Alzheimer’s Disease? If it is true, then treating inflammation could lead to a viable approach to addressing the symptoms of Alzheimer’s.
This link to neuroinflammation could lead to many new treatment options for patients that suffer from autoimmune diseases like alzheimer’s.
If you would like to learn more about how the mechanism of action of low-dose naltrexone mechanism may affect inflammation in the central nervous system through action on the microglial cells.
“We review the evidence that LDN may operate as a novel anti-inflammatory agent in the central nervous system, via action on microglial cells. These effects may be unique to low dosages of naltrexone and appear to be entirely independent from naltrexone’s better-known activity on opioid receptors.”
Learn more about low dose naltrexone and at our next public seminar.
Autoimmune diseases are a complex group of conditions in which the immune system mistakenly attacks healthy cells and tissues. While treatment options exist to manage symptoms, there is no known cure for autoimmune diseases. However, recent research has shed light on the potential benefits of Low Dose Naltrexone (LDN) in managing these conditions. In this blog post, we'll explore some of the latest research findings on the use of LDN in autoimmune diseases.